mRNA-based therapeutics — developing a new class of drugs
暂无分享,去创建一个
[1] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[2] Yurong Lai,et al. Mitochondrial Expression of the Human Equilibrative Nucleoside Transporter 1 (hENT1) Results in Enhanced Mitochondrial Toxicity of Antiviral Drugs* , 2004, Journal of Biological Chemistry.
[3] Z. Berneman,et al. Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial. , 2009, Cytotherapy.
[4] Y. Kaneda,et al. RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization. , 1999, Human gene therapy.
[5] B. Neyns,et al. Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] F. Bloom,et al. Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA. , 1992, Science.
[7] E. Paoletti,et al. Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions. , 1975, The Journal of biological chemistry.
[8] H. Goossens,et al. Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination , 2010, Proceedings of the National Academy of Sciences.
[9] H. Schild,et al. Correction: Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals , 2012, The Journal of Immunology.
[10] E. Ehrenfeld,et al. Comparison of replication complexes synthesizing poliovirus RNA. , 1981, Virology.
[11] P. Fournier,et al. Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine , 2000, Gene Therapy.
[12] Xi-rong Guo,et al. Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA , 2012, Scientific Reports.
[13] K. Chua,et al. DNA vaccines for the prevention and treatment of allergy , 2009, Current opinion in allergy and clinical immunology.
[14] B. Rehermann,et al. The liver as an immunological organ , 2006, Hepatology.
[15] N. Seidah,et al. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides 1 Published on the World Wide Web on 17 August 1999. 1 , 1999, Brain Research.
[16] C. Mandl,et al. RNA-based vaccines. , 2012, Vaccine.
[17] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[18] P. Bevilacqua,et al. Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure‐specific manner , 2008, RNA.
[19] C. Heirman,et al. Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy. , 2012, Cancer research.
[20] Jeffrey Wilusz,et al. The highways and byways of mRNA decay , 2007, Nature Reviews Molecular Cell Biology.
[21] H. Rammensee,et al. Toll‐like receptor‐dependent activation of several human blood cell types by protamine‐condensed mRNA , 2005, European journal of immunology.
[22] E. Gilboa,et al. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA , 1998, Nature Biotechnology.
[23] J. Keith Joung,et al. High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.
[24] H. Rammensee,et al. In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies , 2000 .
[25] S. Barash,et al. Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression. , 2002, Biochemical and biophysical research communications.
[26] P. Lundin. Is silence still golden? Mapping the RNAi patent landscape , 2011, Nature Biotechnology.
[27] N. Schmitz,et al. Generation of Cytotoxic Responses in Mice and Human Individuals Against Hematological Malignancies Using Survivin-RNA-Transfected Dendritic Cells1 , 2003, Journal of Immunology.
[28] T. Hocking,et al. Heritable Targeted Gene Disruption in Zebrafish Using Designed Zinc Finger Nucleases , 2008, Nature Biotechnology.
[29] G. Acsadi,et al. Direct gene transfer into mouse muscle in vivo. , 1990, Science.
[30] S. Akira,et al. Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides , 2006, European journal of immunology.
[31] D. Gallie. The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency. , 1991, Genes & development.
[32] Philip C. Bevilacqua,et al. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation , 2010, Nucleic acids research.
[33] C. Pichon,et al. Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition , 2013, BMC Biotechnology.
[34] W. Keller,et al. Tailing and 3'-end labeling of RNA with yeast poly(A) polymerase and various nucleotides. , 1998, RNA.
[35] Elo Leung,et al. Targeted Genome Editing Across Species Using ZFNs and TALENs , 2011, Science.
[36] H. Rammensee,et al. Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA , 2008, Journal of immunotherapy.
[37] Burkhard Ludewig,et al. Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5 , 2011, Nature Immunology.
[38] J. Castle,et al. Exploiting the mutanome for tumor vaccination. , 2012, Cancer research.
[39] Lianfeng Zhang,et al. Generating Rats with Conditional Alleles Using Crispr/cas9 Dear Editor, Generating Conditional Knockout Rats Using Crispr/cas9 2 Generating Conditional Knockout Rats Using Crispr/cas9 4 , 2022 .
[40] Eli Gilboa,et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. , 2000, Nature Medicine.
[41] Wenzhong Li,et al. Non-viral gene delivery methods. , 2013, Current pharmaceutical biotechnology.
[42] A. J. Shatkin,et al. 5′-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation , 1975, Nature.
[43] S. Krämer,et al. Particle size and activation threshold: a new dimension of danger signaling. , 2010, Blood.
[44] Gunnar Kvalheim,et al. Transiently redirected T cells for adoptive transfer. , 2011, Cytotherapy.
[45] Hiroki Kato,et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[46] Ö. Türeci,et al. Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA , 2007, Cancer Immunology, Immunotherapy.
[47] Yuhua Wang,et al. Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[48] S. Brenner,et al. An Unstable Intermediate Carrying Information from Genes to Ribosomes for Protein Synthesis , 1961, Nature.
[49] Kris Thielemans,et al. Characterization of CD8+ T-Cell Responses in the Peripheral Blood and Skin Injection Sites of Melanoma Patients Treated with mRNA Electroporated Autologous Dendritic Cells (TriMixDC-MEL) , 2013, BioMed research international.
[50] Osamu Takeuchi,et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. , 2009, Immunity.
[51] Elo Leung,et al. Knockout rats generated by embryo microinjection of TALENs , 2011, Nature Biotechnology.
[52] C. Meijer,et al. Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells , 2007, Gene Therapy.
[53] D. Krainc,et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. , 2013, Cell stem cell.
[54] A. Muotri,et al. Efficient generation of human iPSCs by a synthetic self-replicative RNA. , 2013, Cell stem cell.
[55] U. Şahin,et al. Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. , 2010, Cancer research.
[56] H. Rammensee,et al. Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[57] T. Geng,et al. Transfection of cells using flow-through electroporation based on constant voltage , 2011, Nature Protocols.
[58] Jianglin Fan,et al. Effective gene targeting in rabbits using RNA-guided Cas9 nucleases. , 2014, Journal of molecular cell biology.
[59] R. Weiss,et al. Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens. , 2009, The Journal of allergy and clinical immunology.
[60] S. Weissman,et al. Chimeric receptor mRNA transfection as a tool to generate antineoplastic lymphocytes. , 2008, Human gene therapy.
[61] Lei Wang,et al. Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos , 2014, Cell.
[62] K. G. Rajeev,et al. Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.
[63] Yi Zhang,et al. Erythropoietin gene therapy leads to autoimmune anemia in macaques. , 2004, Blood.
[64] S. Bhattacharya,et al. Site Specific Mutation of the Zic2 Locus by Microinjection of TALEN mRNA in Mouse CD1, C3H and C57BL/6J Oocytes , 2013, PloS one.
[65] M. Yanik,et al. Innate Immune Suppression Enables Frequent Transfection with RNA Encoding Reprogramming Proteins , 2010, PloS one.
[66] S. Akira,et al. Activation of MDA5 Requires Higher-Order RNA Structures Generated during Virus Infection , 2009, Journal of Virology.
[67] Alan Villalobos,et al. Engineering genes for predictable protein expression. , 2012, Protein expression and purification.
[68] Vidya Balagopal,et al. Ways and means of eukaryotic mRNA decay. , 2012, Biochimica et biophysica acta.
[69] E. Gilboa,et al. Immunotherapy with Autologous, Human Dendritic Cells Transfected with Carcinoembryonic Antigen mRNA , 2003, Cancer investigation.
[70] J. Rose,et al. Novel infectious particles generated by expression of the vesicular stomatitis virus glycoprotein from a self-replicating RNA , 1994, Cell.
[71] T. Dubensky,et al. An Alphavirus Replicon Particle Chimera Derived from Venezuelan Equine Encephalitis and Sindbis Viruses Is a Potent Gene-Based Vaccine Delivery Vector , 2003, Journal of Virology.
[72] S. Mizutani,et al. In vitro synthesis of an infectious RNA from cDNA clones of human rhinovirus type 14 , 1985, Journal of virology.
[73] D. Weissman,et al. Nucleoside modifications in RNA limit activation of 2′-5′-oligoadenylate synthetase and increase resistance to cleavage by RNase L , 2011, Nucleic acids research.
[74] J. Castle,et al. Targeting the tumor mutanome for personalized vaccination therapy , 2012, Oncoimmunology.
[75] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[76] V. Hornung,et al. Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response. , 2007, Blood.
[77] Andrzej Dziembowski,et al. Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism. , 2010, RNA.
[78] B. Bettencourt,et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. , 2013, The New England journal of medicine.
[79] Donna Niedzwiecki,et al. Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer 1 , 2005, The Journal of Immunology.
[80] S. Yao,et al. Cloning of a human nucleoside transporter implicated in the Cellular uptake of adenosine and chemotherapeutic drugs , 1997, Nature Medicine.
[81] K. Kawakami,et al. Transposon-mediated BAC transgenesis in zebrafish and mice , 2009, BMC Genomics.
[82] S. Fukushima,et al. In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle , 2013, PloS one.
[83] A. Thess,et al. Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect , 2012, The journal of gene medicine.
[84] Thomas Krucker,et al. Nonviral delivery of self-amplifying RNA vaccines , 2012, Proceedings of the National Academy of Sciences.
[85] H. Rammensee,et al. Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients , 2009, Journal of immunotherapy.
[86] C. Broeckhoven,et al. Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells , 1998, Gene Therapy.
[87] D. Weissman,et al. Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[88] Ignacio Anegon,et al. Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases , 2009, Science.
[89] J. Connolly,et al. B Cell TLR7 Expression Drives Anti-RNA Autoantibody Production and Exacerbates Disease in Systemic Lupus Erythematosus–Prone Mice , 2012, The Journal of Immunology.
[90] E. Gilboa,et al. Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells. , 1998, Cancer research.
[91] Jeffry D. Sander,et al. Efficient In Vivo Genome Editing Using RNA-Guided Nucleases , 2013, Nature Biotechnology.
[92] Nicol N. Schraudolph,et al. A Role for Codon Order in Translation Dynamics , 2010, Cell.
[93] S. Grupp,et al. Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemia. , 2013, Human gene therapy.
[94] M. Aoki,et al. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. , 1996, Biochemical and biophysical research communications.
[95] Derrick J. Rossi,et al. Reprogramming human fibroblasts to pluripotency using modified mRNA , 2013, Nature Protocols.
[96] R. Löbenberg,et al. Targeted delivery of nanoparticles for the treatment of lung diseases. , 2008, Advanced drug delivery reviews.
[97] L. Bossi,et al. The influence of codon context on genetic code translation , 1980, Nature.
[98] I. Verma,et al. Cationic liposome-mediated RNA transfection. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[99] Hideyuki Okano,et al. Steps Toward Safe Cell Therapy Using Induced Pluripotent Stem Cells , 2013, Circulation research.
[100] B. Neyns,et al. Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[101] K. P. Murphy,et al. Janeway's immunobiology , 2007 .
[102] A. van Hoof,et al. Messenger RNA regulation: to translate or to degrade , 2008, The EMBO journal.
[103] D. Weissman,et al. Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA , 2011, Nucleic acids research.
[104] D. Melton,et al. Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. , 1984, Nucleic acids research.
[105] J. A. Bernal. RNA-Based Tools for Nuclear Reprogramming and Lineage-Conversion: Towards Clinical Applications , 2013, Journal of Cardiovascular Translational Research.
[106] K. Zdanowski,et al. Eukaryotic translation initiation is controlled by cooperativity effects within ternary complexes of 4E‐BP1, eIF4E, and the mRNA 5′ cap , 2013, FEBS letters.
[107] E. Gilboa,et al. The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer , 2002, International journal of gastrointestinal cancer.
[108] H. Conjeevaram,et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. , 1995, The New England journal of medicine.
[109] S. Yoon,et al. Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model , 2009, Cancer Gene Therapy.
[110] J. Ross,et al. Half-lives of beta and gamma globin messenger RNAs and of protein synthetic capacity in cultured human reticulocytes. , 1985, Blood.
[111] D. Campana,et al. Synthetic messenger RNA as a tool for gene therapy. , 2006, Human gene therapy.
[112] D. Tollervey,et al. The Many Pathways of RNA Degradation , 2009, Cell.
[113] Michael J. Davis,et al. Sensing prokaryotic mRNA signifies microbial viability and promotes immunity , 2011, Nature.
[114] G. Rhodes,et al. Self-replicating Semliki Forest virus RNA as recombinant vaccine. , 1994, Vaccine.
[115] Ö. Türeci,et al. Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation , 2011, Gene Therapy.
[116] E. Neumann,et al. Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.
[117] T. Schlake,et al. Protein expression from exogenous mRNA: Uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway , 2011, RNA biology.
[118] D. Weissman,et al. HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response1 , 2000, The Journal of Immunology.
[119] R. Rhoads,et al. Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells. , 2007, RNA.
[120] Y. Lai,et al. Identification of the Mitochondrial Targeting Signal of the Human Equilibrative Nucleoside Transporter 1 (hENT1) , 2006, Journal of Biological Chemistry.
[121] D. Givol,et al. Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. , 2010, Biochemical and biophysical research communications.
[122] U. Şahin,et al. mRNA as a versatile tool for exogenous protein expression. , 2012, Current gene therapy.
[123] K Nakayama,et al. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. , 1997, The Biochemical journal.
[124] E. Gilboa,et al. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo , 1996, The Journal of experimental medicine.
[125] J. Wilusz,et al. Lsm proteins bind and stabilize RNAs containing 5′ poly(A) tracts , 2007, Nature Structural &Molecular Biology.
[126] Elmar Wahle,et al. Poly(A) Tail Shortening by a Mammalian Poly(A)-specific 3′-Exoribonuclease* , 1997, The Journal of Biological Chemistry.
[127] Chow H Lee,et al. Endoribonucleases – enzymes gaining spotlight in mRNA metabolism , 2010, The FEBS journal.
[128] R. Vale,et al. Circularization of mRNA by eukaryotic translation initiation factors. , 1998, Molecular cell.
[129] Ö. Türeci,et al. Tumor vaccination using messenger RNA: prospects of a future therapy. , 2011, Current opinion in immunology.
[130] K. Jacobson,et al. Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. , 1975, Biochimica et biophysica acta.
[131] C. Heirman,et al. mRNA , 2013, Human Vaccines & Immunotherapeutics.
[132] M. Pfreundschuh,et al. Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[133] N. Seidah,et al. Precursor Convertases: An Evolutionary Ancient, Cell‐Specific, Combinatorial Mechanism Yielding Diverse Bioactive Peptides and Proteins , 1998, Annals of the New York Academy of Sciences.
[134] J. Slater,et al. The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine. , 1998, The Journal of allergy and clinical immunology.
[135] C. Figdor,et al. Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients , 2012, Clinical Cancer Research.
[136] U. Şahin,et al. Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studies. , 2013, Methods in molecular biology.
[137] Wolfgang Wurst,et al. Generation of targeted mouse mutants by embryo microinjection of TALEN mRNA , 2013, Nature Protocols.
[138] E. Gilboa,et al. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. , 2002, The Journal of clinical investigation.
[139] Rudolf Jaenisch,et al. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.
[140] D. G. Gibson,et al. Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice , 2013, Emerging Microbes & Infections.
[141] Patrick Mayeux,et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. , 2002, The New England journal of medicine.
[142] P. Roberts,et al. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. , 2000, Immunity.
[143] R. Rhoads,et al. Synthesis and properties of mRNAs containing the novel "anti-reverse" cap analogs 7-methyl(3'-O-methyl)GpppG and 7-methyl (3'-deoxy)GpppG. , 2001, RNA.
[144] N. Yang,et al. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. , 1996, Gene therapy.
[145] F. Altmann,et al. Comprehensive glyco‐proteomic analysis of human α1‐antitrypsin and its charge isoforms , 2006, Proteomics.
[146] C. Pichon,et al. mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level. , 2006, Biochemical and biophysical research communications.
[147] Aristóbolo Mendes Silva,et al. Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis , 2010, BMC biotechnology.
[148] Bernard Verrier,et al. Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins. , 2006, Blood.
[149] M. Hilleman,et al. Inducers of interferon and host resistance. 3. Double-stranded RNA from reovirus type 3 virions (reo 3-RNA). , 1967, Proceedings of the National Academy of Sciences of the United States of America.
[150] U. Şahin,et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. , 2006, Blood.
[151] H. Goossens,et al. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients , 2012, AIDS.
[152] E. Levine,et al. Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[153] J. Wilusz. RNA stability: is it the endo' the world as we know it? , 2009, Nature Structural &Molecular Biology.
[154] Corey M. Carlson,et al. Mammalian germ-line transgenesis by transposition , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[155] Ö. Türeci,et al. FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines. , 2011, Cancer research.
[156] H. Schellekens,et al. Antibodies against Erythropoietin and Other Protein‐Based Therapeutics: An Overview , 2005, Annals of the New York Academy of Sciences.
[157] M. Kiledjian,et al. Regulation of mRNA decapping , 2010, Wiley interdisciplinary reviews. RNA.
[158] R. Valenta,et al. From allergen genes to allergy vaccines. , 2010, Annual review of immunology.
[159] D. Kufe,et al. Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA1 , 2000, The Journal of Immunology.
[160] G. Vanham,et al. Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[161] M. Fotin‐Mleczek,et al. Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity , 2011, Journal of immunotherapy.
[162] H. Rammensee,et al. The regulatory landscape for actively personalized cancer immunotherapies , 2013, Nature Biotechnology.
[163] R. Granstein,et al. Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA. , 2000, The Journal of investigative dermatology.
[164] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[165] C. Fathman,et al. A short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[166] Lippincott-Schwartz,et al. Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .
[167] E. G. Westaway,et al. Subgenomic replicons of the flavivirus Kunjin: construction and applications , 1997, Journal of virology.
[168] P. Eilers,et al. A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption. , 2012, Clinical immunology.
[169] D. Harrich,et al. Kunjin Virus Replicon Vaccine Vectors Induce Protective CD8+ T-Cell Immunity , 2002, Journal of Virology.
[170] K. Miura,et al. A blocked structure at the 5′ terminus of mRNA from cytoplasmic polyhedrosis virus , 1975, Nature.
[171] P. Liljeström,et al. A New Generation of Animal Cell Expression Vectors Based on the Semliki Forest Virus Replicon , 1991, Bio/Technology.
[172] K. Dyer,et al. The RNase a superfamily: Generation of diversity and innate host defense , 2006, Molecular Diversity.
[173] M. Bonneville,et al. +1 Frameshifting as a Novel Mechanism to Generate a Cryptic Cytotoxic T Lymphocyte Epitope Derived from Human Interleukin 10 , 2002, The Journal of experimental medicine.
[174] C. Mandl,et al. In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model , 1998, Nature Medicine.
[175] R. Hewson. RNA viruses: emerging vectors for vaccination and gene therapy. , 2000, Molecular medicine today.
[176] K. Lundstrom. Alphaviruses in Gene Therapy , 2009, Viruses.
[177] B. Levine,et al. T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans , 2013, Cancer Immunology Research.
[178] R. Rhoads,et al. Novel "anti-reverse" cap analogs with superior translational properties. , 2003, RNA.
[179] J. Sampson,et al. Selective modification of antigen-specific T cells by RNA electroporation. , 2008, Human gene therapy.
[180] C. Mandl,et al. RNA: the new revolution in nucleic acid vaccines. , 2013, Seminars in immunology.
[181] Gunther Hartmann,et al. 5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.
[182] Y. Uematsu,et al. A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge. , 2007, Vaccine.
[183] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[184] N. Schmitz,et al. Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies. , 2003, Blood.
[185] K. Kawakami,et al. A simple and highly efficient transgenesis method in mice with the Tol2 transposon system and cytoplasmic microinjection. , 2010, Genomics.
[186] Jun Zhang,et al. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting , 2013, Cell Research.
[187] Ö. Türeci,et al. Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo , 2010, Gene Therapy.
[188] W. Lewis. Defective mitochondrial DNA replication and NRTIs: pathophysiological implications in AIDS cardiomyopathy. , 2003, American journal of physiology. Heart and circulatory physiology.
[189] M. Czech,et al. RNAi-based therapeutic strategies for metabolic disease , 2011, Nature Reviews Endocrinology.
[190] Viswanath Devanarayan,et al. Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products. , 2008, Journal of immunological methods.
[191] J. H. Strauss,et al. Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants , 1987, Journal of virology.
[192] Tao Wang,et al. Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies. , 2012, International journal of pharmaceutics.
[193] D. Curiel,et al. Characterization of a messenger RNA polynucleotide vaccine vector. , 1995, Cancer research.
[194] G. Ciliberto,et al. Gene electro‐transfer of an improved erythropoietin plasmid in mice and non‐human primates , 2005, The journal of gene medicine.
[195] V. M. Pain,et al. A Reevaluation of the Cap-binding Protein, eIF4E, as a Rate-limiting Factor for Initiation of Translation in Reticulocyte Lysate (*) , 1996, The Journal of Biological Chemistry.
[196] M. Idzko,et al. Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism. , 2013, The Journal of clinical investigation.
[197] A. Thess,et al. A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs , 2014, Therapeutic advances in vaccines.
[198] F. Marincola,et al. Cancer therapy using a self-replicating RNA vaccine , 1999, Nature Medicine.
[199] Timothy B. Stockwell,et al. Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics , 2013, Science Translational Medicine.
[200] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[201] E. Gilboa,et al. Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 41 , 2004, The Journal of Immunology.
[202] G. Lenzen,et al. Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA , 1993, European journal of immunology.
[203] E. Raz,et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[204] B. Levine,et al. Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. , 2010, Cancer research.
[205] B. Neyns,et al. Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient , 2012, Cancer Immunology, Immunotherapy.
[206] N. Shastri,et al. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. , 1999, Immunity.
[207] G. J. Dimitriadis. Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes , 1978, Nature.
[208] Alexander Meissner,et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.
[209] C. Y. Chen,et al. AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.
[210] J. Rosenecker,et al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice , 2011, Nature Biotechnology.
[211] Ralf Dahm,et al. Friedrich Miescher and the discovery of DNA. , 2005, Developmental biology.
[212] R. Behringer,et al. Insertional Mutagenesis by a Hybrid PiggyBac and Sleeping Beauty Transposon in the Rat , 2012, Genetics.
[213] Ronald A. Li,et al. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction , 2013, Nature Biotechnology.
[214] M. F. Mallette,et al. The use of basic proteins to increase the infectivity of enterovirus ribonucleic acid , 1961 .
[215] S. Govindarajan,et al. Codon bias and heterologous protein expression. , 2004, Trends in biotechnology.
[216] S. Aamdal,et al. Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA , 2006, Cancer Gene Therapy.
[217] D. Baltimore,et al. Cloned poliovirus complementary DNA is infectious in mammalian cells. , 1981, Science.
[218] Vladimir Torchilin,et al. Tumor delivery of macromolecular drugs based on the EPR effect. , 2011, Advanced drug delivery reviews.
[219] Shizuo Akira,et al. Shared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, and LGP2 in Antiviral Innate Immunity1 , 2005, The Journal of Immunology.
[220] M. Debenedette,et al. Cytokine Maturation Followed by CD40L mRNA Electroporation Results in a Clinically Relevant Dendritic Cell Product Capable of Inducing a Potent Proinflammatory CTL Response , 2008, Journal of immunotherapy.
[221] J. Gurdon,et al. Use of Frog Eggs and Oocytes for the Study of Messenger RNA and its Translation in Living Cells , 1971, Nature.
[222] K. Karikó,et al. Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA , 1999, Gene Therapy.
[223] R. E. Lockard,et al. The synthesis of mouse hemoglobin beta-chains in a rabbit reticulocyte cell-free system programmed with mouse reticulocyte 9S RNA. , 1969, Biochemical and biophysical research communications.
[224] Samira Kiani,et al. Genetic engineering of human ES and iPS cells using TALE nucleases , 2011, Nature Biotechnology.
[225] R. Rhoads,et al. Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS. , 2008, RNA.
[226] R. A. Cox,et al. Foreign nucleic acids as the stimulus to make interferon. , 1963, Lancet.
[227] D. Largaespada,et al. RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[228] B. Neyns,et al. A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[229] B. Neyns,et al. Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma , 2011, Journal of immunotherapy.
[230] T. Thalhamer,et al. Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice , 2015, Journal of immunology research.
[231] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 2007, Journal of immunology.
[232] S. Pascolo. Vaccination with messenger RNA (mRNA). , 2008, Handbook of experimental pharmacology.
[233] T. Schlake,et al. Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection , 2012, Nature Biotechnology.
[234] N. Shastri,et al. Constitutive Display of Cryptic Translation Products by MHC Class I Molecules , 2003, Science.
[235] Adam James Waite,et al. An improved zinc-finger nuclease architecture for highly specific genome editing , 2007, Nature Biotechnology.
[236] H. Rammensee,et al. Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines , 2004, Cellular and Molecular Life Sciences CMLS.
[237] B. Neyns,et al. Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients , 2009, Clinical Cancer Research.
[238] Houping Ni,et al. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. , 2005, Immunity.
[239] Mehmet Fatih Yanik,et al. mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. , 2013, Blood.
[240] T. Tagawa,et al. Bax mRNA therapy using cationic liposomes for human malignant melanoma , 2008, Journal of Gene Medicine.
[241] Clay W Scott,et al. Human induced pluripotent stem cells and their use in drug discovery for toxicity testing. , 2013, Toxicology letters.
[242] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[243] J. Keene,et al. Autoimmune epitopes in messenger RNA. , 2002, RNA.
[244] N. Sang,et al. Engineering Factor Viii for Hemophilia Gene Therapy. , 2011, Journal of genetic syndromes & gene therapy.
[245] C. Rice,et al. Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. , 1989, Science.
[246] S. Grupp,et al. Treatment of advanced leukemia in mice with mRNA engineered T cells. , 2011, Human gene therapy.
[247] W. Rottbauer,et al. Successful Use of mRNA-Nucleofection for Overexpression of Interleukin-10 in Murine Monocytes/Macrophages for Anti-inflammatory Therapy in a Murine Model of Autoimmune Myocarditis , 2012, Journal of the American Heart Association.
[248] H. Schild,et al. Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals1 , 2008, The Journal of Immunology.
[249] L. Silbart,et al. Modulating gene expression using DNA vaccines with different 3'-UTRs influences antibody titer, seroconversion and cytokine profiles. , 2003, Vaccine.
[250] M. Murphy,et al. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus. , 2001, The Journal of infectious diseases.
[251] Ö. Türeci,et al. mTOR Inhibition Improves Antitumor Effects of Vaccination with Antigen-Encoding RNA , 2013, Cancer Immunology Research.
[252] J. Routy,et al. Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy. , 2010, Clinical immunology.